Provinces are fifth and sixth in Canada to reimburse new metastatic prostate cancer treatment Toronto, ON (May 16, 2012) – Men living with metastatic prostate cancer in Nova Scotia and Newfoundland and
Tag: Access
ZYTIGA™* (abiraterone acetate) receives Health Canada approval for treatment for metastatic prostate cancer
First Oral Treatment for Metastatic Prostate Cancer That Inhibits Androgen Production at All Three Sources Toronto, ON, July 28, 2011– Janssen Inc. announced today that after a priority review, Health Canada has